Form 4: Know Labs CEO Ronald Erickson Acquires 100,000 Shares of Common Stock
SEC Form 4 Filing
Know Labs CEO Ronald Erickson reports acquiring 100,000 shares of common stock at $0.44 per share on May 5, 2025, while also disposing of 137,202 shares.
Summary
- On May 5, 2025, Ronald P. Erickson, CEO of Know Labs, Inc., acquired 100,000 shares of common stock at a price of $0.44 per share.
- Following this transaction, Erickson directly owns 137,202 shares of Know Labs common stock.
- Erickson also holds warrants to purchase common stock at various exercise prices and expiration dates.
- Some warrants are held directly, while others are held indirectly through J3E2A2Z Limited Partnership, an affiliated entity.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The CEO's purchase is a positive sign, but the disposal of shares offsets this. The warrant holdings are a standard part of executive compensation.
Positives
- The CEO's purchase of 100,000 shares could be interpreted as a sign of confidence in the company's future prospects.
Negatives
- The disposal of 137,202 shares by the CEO could be interpreted negatively by investors.
Risks
- The warrants held by the CEO could dilute existing shareholders if exercised.
- The high exercise price of some warrants ($61.2) may indicate a previous valuation that the company has not yet achieved.
Industry Context
Insider transactions are closely watched as indicators of management's confidence in the company's prospects. A mix of acquisition and disposal makes it difficult to assess the overall sentiment.
Comparison to Industry Standards
- Comparing the warrant exercise prices to the current stock price ($0.44) suggests that the company's valuation has changed significantly since the warrants were issued.
- Similar companies in the technology sector often have executive compensation packages that include stock options and warrants, but the specific terms vary widely based on company size, stage of development, and industry norms.
Related Party Transactions
- The warrant holdings by J3E2A2Z Limited Partnership, an entity affiliated with Ronald P. Erickson, constitute a related party transaction.
Stakeholder Impact
- The CEO's stock transactions may influence investor sentiment and potentially impact the stock price.
- The potential dilution from warrant exercises could affect shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/31/2018 | Date of warrant issuance for warrants expiring on 01/31/2026. |
| 12/15/2020 | Date of warrant issuance for warrants expiring on 12/15/2025. |
| 01/31/2026 | Expiration date for warrants to purchase 21,375 and 25,992 shares at $9.6. |
| 12/15/2025 | Expiration date for warrants to purchase 50,000 shares at $61.2. |
| 05/05/2025 | Date of common stock acquisition and disposal. |
| 05/07/2025 | Date of Form 4 filing. |
Keywords
Form 4, insider trading, beneficial ownership, Ronald Erickson, Know Labs, KNW, common stock, warrants, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.